Interferon Therapy (HCV)
"Expression of Interferon Receptor Genes in the Liver as a Predictor of Interferon Response in Patients with Chronic Hepatitis C."
Published in Hepatitis Weekly, August 16th, 1999
According to the authors' abstract of an article published in Journal of Medical Virology, "Interferon (IFN) receptor mRNA expression patterns in the liver have been shown to correlate with the effectiveness of IFN therapy in patients with hepatitis C virus (HCV) infection. However, it is not clear to what extent this factor contributes to the short (primary)- and long (sustained)-term results of IFN treatment with respect to biochemical and virological remission. Eighty-two patients who subsequently received lymphoblastoid IFN-alpha therapy underwent liver biopsies before IFN therapy. Possible factors that might correlate with IFN response were chosen and analyzed. The primary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1999-08-16)
More Articles from Hepatitis Weekly
- Therapy
IFN Useful in HCV Patients with Cirrhosis - Disease Markers
Portal Lymphadenopathy Suggests Liver Damage in HCV+ - Genomics
Cyclin D1 Gene Plays Role in Hepatitis-Related Cancer - Research & Development
NIH Announces 8-Year Hepatitis Therapy Study - Risk Factors
IFN Therapy Reduces Liver Cancer in HCV Patients - Therapy
Prior Mood/Anxiety Problems Don't Preclude IFN Treatment - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
